The same highly significant impact was registered for migraine-related disability, anxiety and depressive symptoms, allodynia, and fatigue, as summarized in Table 1 .
← all excerpts
Beyond Pain Relief: Unveiling the Multifaceted Impact of Anti-CGRP/R mAbs on Comorbid Symptoms in Resistant Migraine Patients.
1
—
—